Nosa Med AB (NOSA) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.08x
Nosa Med AB (NOSA) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of Skr-1.78 Million could theoretically repay 0% of its total liabilities (Skr23.65 Million) in one year. See financial flexibility index of Nosa Med AB to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.08x
Operating CF / Total Liabilities
Operating Cash Flow
Skr-1.78 Million
SEK
Total Liabilities
Skr23.65 Million
SEK
Data as of
Dec 2025
Most recent filing
Nosa Med AB Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Nosa Med AB across 10 annual periods. For the full cash flow conversion analysis, see Nosa Med AB cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Nosa Med AB (2016–2025)
Year-by-year debt coverage analysis for Nosa Med AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | Skr-6.39 Million | Skr23.65 Million | ▲ +88.8% |
| 2024 | -2.42x | Skr-10.03 Million | Skr4.14 Million | ▲ +12.4% |
| 2023 | -2.76x | Skr-17.50 Million | Skr6.33 Million | ▼ -33.0% |
| 2022 | -2.08x | Skr-6.93 Million | Skr3.33 Million | ▲ +67.2% |
| 2021 | -6.33x | Skr-6.21 Million | Skr980.00K | ▼ -32.3% |
| 2020 | -4.79x | Skr-69.96 Million | Skr14.61 Million | ▼ -43.4% |
| 2019 | -3.34x | Skr-52.72 Million | Skr15.79 Million | ▼ -35.2% |
| 2018 | -2.47x | Skr-35.09 Million | Skr14.21 Million | ▲ +33.4% |
| 2017 | -3.71x | Skr-27.78 Million | Skr7.49 Million | ▲ +43.2% |
| 2016 | -6.53x | Skr-23.48 Million | Skr3.60 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.